Report Id: SNS/HC/2648 | July 2022 | Region: Global | 133 Pages
Report Scope & Overview:
The Nano Biotechnology Market Size was valued at USD 6.48 billion in 2022, and expected to reach USD 13.79 billion by 2030, and grow at a CAGR of 9.9% over the forecast period 2023-2030.
Nano biotechnology is a special combination of nano medicine and biotechnology in which conventional microtechnology is combined with a molecular biological approach. It has the ability to promote medical research and enhance healthcare systems everywhere. The ongoing COVID-19 outbreak serves as a reminder of the value of immunizations. The creation of vaccinations can be sped up with the help of nanobiotechnology. Offering novel medicine formulations with fewer adverse effects is also beneficial. Nano biotechnology will be used in the future to create novel materials and machinery for use in electronics, medicine, biomaterials, and energy generation.
More money being spent on studies in nanobiotechnology
The treatment of chronic diseases is in high demand.
R&D is expensive.
Nanobiotechnology is becoming more widely used in a variety of industries.
People are becoming more prone to chronic diseases.
Lengthy and costly procedure
IMPACT OF COVID-19
Worldwide operational facilities have been shut down as a result of the current COVID-19 illness pandemic, which has affected individuals all over the world. During the lockdown period, the healthcare sector experienced unprecedented situations. Medical device and other healthcare product output was impacted by the closure of the manufacturing facilities. Additionally, the supply chain for medical supplies was impacted, which increased the inventory of manufactured goods in warehouses. Businesses involved in the nanobiotechnology business are benefiting from this COVID-19 epidemic as well. Nanobiotechnology can be used to create quick test kits for COVID-19 antigen detection.
Nanobiotechnology is being used to create new medicines for a variety of diseases. It can be used to create important pharmaceutical formulations. It aids in the delivery of targeted drugs, which is beneficial in the treatment of chronic diseases.
Nanomaterials created through nanobiotechnology allow for the creation of novel, tunable medical devices for a variety of applications. In vitro diagnostic devices, wound dressings, orthopedic and vascular grafts, dental implants, stents, vascular closure devices, bone void fillers, embolization protection devices, catheters, and heart valves are among the devices included in this category.
The potential of nano biotechnology to advance medical science is enormous. It includes a plethora of tools for monitoring individual cells down to the level of individual molecules. These tools aid in the investigation and monitoring of molecular and cellular functions.
Nano biotechnology has numerous applications in the food and agriculture industries. Nano fertilizers created with nanobiotechnology aid in plant growth.
There are many applications for nano biotechnology in dental practices. It includes dentine hypersensitivity therapy, dentition renaturalization, complete orthodontic alignment, improvement of root canal sealing properties, covalent bonding of diamond enamel, and continuous oral health maintenance using mechanical dental nanorobots.
Nano biotechnology has a wide range of applications in cardiac therapies, including the ability to treat faulty heart valves, detect and treat arterial plaque, and help researchers develop better treatments.
Nanotechnology has the potential to develop advanced orthopedic diagnosis and treatment options. It is used to make orthopedic implants for patients.
The nano biotech market has numerous therapeutic applications, such as lung regeneration. It helps patients overcome various physical problems.
Some of the major key players are as follows: Ablynx, Celgene Corporation, Dabur Pharma, Nano Bridging Molecules SA, Sigma-Aldrich, Nami Therapeutics, XanTecbioanalytics GmbH, SkyePharma Pharmaceuticals, Nanobiotix, Nanophase Technologies Corporation.
Food and Agriculture
The largest market share for nanobiotechnology will be in North America. High expenditures on R&D initiatives, reputable institutions for product development research, government initiatives to improve the healthcare system, and rising end-user demand are all variables that affect this share. To grow their businesses, the major players are spending money on the research and development of new products.
It is anticipated that the European nanobiotechnology market would have a sizable market share. The market is growing as a result of strong consumer demand for products with cutting-edge technology and robust R&D facilities. The development of new products using cutting-edge technology, significant investments by industry players, and government support are all contributing to the market's expansion.
Asia-Pacific is anticipated to be the area with the quickest rate of growth throughout the projected period as a result of increased investments in healthcare infrastructure and an increase in the prevalence of chronic illnesses like cardiovascular and neurological diseases. Additionally, greater government funding for the expansion of the healthcare system offers opportunities for business participants.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 6.48 Billion|
|Market Size by 2030||US$ 13.79 Billion|
|CAGR||CAGR of 9.9% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Application (Pharmaceuticals, Medical Devices, Medical Research, Food and Agriculture)
• By Therapeutics (Dental Therapies, Cardiac Therapies, Orthopedic Therapies, Others)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Ablynx, Celgene Corporation, Dabur Pharma, Nano Bridging Molecules SA, Sigma-Aldrich, Nami Therapeutics, XanTecbioanalytics GmbH, SkyePharma Pharmaceuticals, Nanobiotix, Nanophase Technologies Corporation.|
|Key Drivers||• More money being spent on studies in nanobiotechnology
• The treatment of chronic diseases is in high demand.
|RESTRAINTS||• R&D is expensive.
• Technology Evaluation
Frequently Asked Questions (FAQ) :
Nano Biotechnology Market Size was expected to reach USD 10 billion by 2028.
Pharmaceuticals, Medical Devices, Medical Research, and Food and Agriculture are sub segments of by application of Nano Biotechnology market.
Nano biotechnology is a special combination of nano medicine and biotechnology in which conventional microtechnology is combined with a molecular biological approach. It has the ability to promote medical research and enhance healthcare systems everywhere
Ablynx, Celgene Corporation, Dabur Pharma, Nano Bridging Molecules SA, Sigma-Aldrich, Nami Therapeutics, and XanTec bioanalytics GmbH, are key players of Nano Biotechnology Market.
Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Nano Biotechnology Market Segmentation, By Application
8.2 Medical Devices
8.3 Medical Research
8.4 Food and Agriculture
9. Nano Biotechnology Market Segmentation, By Therapeutics
9.1 Dental Therapies
9.2 Cardiac Therapies
9.3 Orthopedic Therapies
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Celgene Corporation
11.3 Dabur Pharma
11.4 Nano Bridging Molecules SA
11.6 Nami Therapeutics
11.7 XanTecbioanalytics GmbH
11.8 SkyePharma Pharmaceuticals
11.10 Nanophase Technologies Corporation
12.1 Competitive Benchmark
12.2 Market Share analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of the good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.